Clin Mol Hepatol.
2025 Feb;31(Suppl):S1-S31. 10.3350/cmh.2025.0045.
KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025
- Sohn W1
- Lee YS2
- Kim SS3
- Kim JH4
- Jin YJ5
- Kim GA6
- Sung PS7
- Yoo JJ8
- Chang Y9
- Lee EJ10
- Lee HW11
- Choi M12
- Yu SJ13
- Jung YK
14 - Jang BK15
- on behalf of The Korean Association for the Study of the Liver (KASL)1
- Affiliations
-
- 1Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
- 2Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
- 3Department of Internal Medicine, Ajou University School of Medicine, Suwon, Korea
- 4Department of Internal Medicine, Dongtan Sacred Heart Hospital, Hallym University School of Medicine, Hwaseong, Korea
- 5Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, Korea
- 6Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul, Korea
- 7Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
- 8Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
- 9Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea
- 10Department of Pediatrics, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
- 11Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
- 12Clinical Evidence Research, National Evidence-Based Healthcare Collaborating Agency, Seoul, Korea
- 13Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
- 14Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea
- 15Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea
- KMID: 2565369
- DOI: http://doi.org/10.3350/cmh.2025.0045
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A new Korean nomenclature for steatotic liver disease: Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
- A complement to epigenetics in metabolic dysfunction-associated steatotic liver disease: Editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease”
- Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease: Editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”
- Ursolic acid: A promising therapeutic agent for metabolic dysfunction-associated steatotic liver disease via inhibition of SPP1-induced Th17 cell differentiation: Editorial on “Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease”
- The new definition of metabolic dysfunction-associated steatotic liver disease: the role of ultrasound and elastography
